Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252859 · ClinicalTrials.gov registry record · Phase 2
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
A Phase 2 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT04252859 is a Phase 2 study that was terminated before completion, run by University of Utah. The registered enrollment target is 44 participants.
The verdict
NCT04252859, a Phase 2 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
FES PET/CT imaging for invasive lobular cancer
Interventions
- DRUG [18F]Fluoroestradiol (FES) PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-12-11 |
| Est. Completion | 2024-12-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04252859
The ClinicalTrials.gov registry entry for NCT04252859 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]Fluoroestradiol (FES) PET/CT is the first listed.
NCT04252859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04252859 about?
NCT04252859 is a clinical study titled "[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma". FES PET/CT imaging for invasive lobular cancer
What is the current status of trial NCT04252859?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2020-12-11. Estimated completion is 2024-12-07.
What interventions are being tested in trial NCT04252859?
The interventions under investigation include: [18F]Fluoroestradiol (FES) PET/CT (DRUG).
Who is sponsoring clinical trial NCT04252859?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.